In a mice model of DIC, TRPC6 deficiency provides cardioprotection against doxorubicin-induced cardiac damage and cardiomyopathy in male mice, highlighting that TRPC6 plays a critical role in promoting cardiac toxicity during chemotherapy. This evidence concerns the gene TRPC6 and cardiomyopathy.